MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 21 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $46,000 | +2200.0% | 17,925 | +1984.3% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 860 | -52.0% | 0.00% | – |
| Q3 2019 | $2,000 | -85.7% | 1,791 | -61.9% | 0.00% | -100.0% |
| Q4 2018 | $14,000 | +600.0% | 4,698 | +1786.7% | 0.00% | – |
| Q3 2018 | $2,000 | +100.0% | 249 | -31.0% | 0.00% | – |
| Q1 2018 | $1,000 | -92.9% | 361 | -79.0% | 0.00% | -100.0% |
| Q4 2017 | $14,000 | – | 1,719 | – | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2017 | $7,000 | +250.0% | 5,201 | +297.3% | 0.00% | – |
| Q1 2017 | $2,000 | -80.0% | 1,309 | -84.2% | 0.00% | -100.0% |
| Q2 2016 | $10,000 | +100.0% | 8,260 | +813.7% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | +150.0% | 904 | +352.0% | 0.00% | – |
| Q3 2015 | $2,000 | -33.3% | 200 | -33.3% | 0.00% | – |
| Q1 2015 | $3,000 | -92.7% | 300 | -92.3% | 0.00% | -100.0% |
| Q4 2014 | $41,000 | +24.2% | 3,908 | -24.5% | 0.00% | 0.0% |
| Q3 2014 | $33,000 | – | 5,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |